Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted ...

Envoy Medical, Inc.: Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions ...
101 Great Goals

Tottenham v Copenhagen: Line-ups, stats and preview

Read our in-depth Champions League preview as Spurs boss Thomas Frank prepares to renew his rivalry with Copenhagen.
GolfMagic

Scottie Scheffler makes announcement with brand new deal ahead of 2026 PGA Tour season

Scottie Scheffler after signing new deal: "I’m incredibly particular and selective about the brands I work with..." ...
MassDevice

Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes

Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...
MassDevice

Lungpacer enrolls first patients in next-gen neurostim trial

Lungpacer Medical announced today that it enrolled the first six patients in its STARI clinical trial for its next-generation AeroNova system.
Becker's Hospital Review

UPS scoops healthcare supplier for $1.6B

UPS scoops healthcare supplier Andlauer Healthcare Group for $1.6 billion, expanding its cold chain and logistics services in Canada.

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss

The extension of indication authorizes use in individuals with spinal cord injury (SCI) from levels C4 to L5 and in those with multiple sclerosis (MS), broadening access to upright, hands-free gait ...